Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Simon Roger, MD
Renal Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Renal Research
Gosford, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Boxhill Hospital
Box Hill, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Melbourne Renal Research Group
Melbourne, Victoria, Australia
- Royal Melbourne Hospital
Melbourne, Victoria, Australia
- St Vincents Hospital
Melbourne, Victoria, Australia
- Sunshine Hospital
Melbourne, Victoria, Australia
- Epworth Hospital
Richmond, Victoria, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Nov 2018
- Primary completion
- 23 Jul 2020
- Completion
- 18 Aug 2020
- Last update posted
- 29 Jul 2022
- Registered enrollment
- 45
- Registry id
- NCT03627715
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.